In support of the U.S. government’s policy to maintain a stockpile to be able to protect every American from smallpox, Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract award by the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS) valued at approximately $2 billion over 10 years for the continued supply of ACAM2000®, (Smallpox (Vaccinia) Vaccine, Live) into the U.S. Strategic National Stockpile (SNS). The actual number of ACAM2000 doses to be procured is dependent on certain timing and tiered-pricing terms that are subject to the discretion of ASPR. ACAM2000 vaccine is the only vaccine licensed by the


Calling all entrepreneurs and Innovators in the DMV area… Have you heard? JLABS @ Washington DC is coming to the District! In anticipation of our upcoming launch we are hosting a community mixer.  This is a wonderful opportunity for those looking to expand your network, connect with other entrepreneurs, VCs, academics and industry leaders. You’ll get an chance to meet the local JLABS Team, learn about future programming and how to become a resident.


Here are seven pieces of wisdom and advice about the role of innovation in healthcare that executives from hospitals and health systems across the country shared with Becker's Hospital Review in August: